Alprazolam | UCB
UCB's Global Corporate Website

Alprazolam

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Anxiety A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety Phase 3 SP0829
Completed
NCT00139854 PDF
Mild Asthma A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma Phase 1 UP0099
Completed
NCT04802746
Epilepsy A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy Phase 1 UP0100
Completed
NCT04857307